I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Sandborn, W.
617
results:
Search for persons
X
Format
Online (617)
Mediatypes
Articles (Online) (529)
Bookchapter (Online) (1)
OpenAccess-fulltext (87)
Languages
english (598)
french (2)
Sorted by: Relevance
Sorted by: Year
?
1
P957 Subcutaneous infliximab (CT-P13 SC) for ulcerative col..:
Sands, B E
;
Hanauer, S B
;
Colombel, J F
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1737-i1738 , 2024
Link:
https://doi.org/10.1093/..
?
2
OP03 Efficacy and safety of the oral selective sphingosine-..:
Sands, B E
;
Panaccione, R
;
D'Haens, G
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i4-i5 , 2024
Link:
https://doi.org/10.1093/..
?
3
DOP11 Disease clearance after 16 weeks of treatment with ve..:
Jairath, V
;
Zou, G
;
Adsul, S
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i92-i93 , 2024
Link:
https://doi.org/10.1093/..
?
4
P902 Subcutaneous infliximab (CT-P13 SC) as maintenance the..:
Colombel, J F
;
Hanauer, S B
;
Sandborn, W J
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1653-i1654 , 2024
Link:
https://doi.org/10.1093/..
?
5
P588 Interim results from the randomised VERDICT trial to d..:
Jairath, V
;
Zou, G
;
Wang, Z
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i716-i717 , 2023
Link:
https://doi.org/10.1093/..
?
6
DOP86 Subcutaneous infliximab (CT-P13 SC) as maintenance th..:
Colombel, J F
;
Hanauer, S B
;
Sandborn, W
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i161-i162 , 2023
Link:
https://doi.org/10.1093/..
?
7
OP15 Efficacy of ustekinumab for Ulcerative Colitis through..:
Danese, S
;
Afif, W
;
Abreu, M
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i19-i20 , 2023
Link:
https://doi.org/10.1093/..
?
8
P748 Pharmacokinetics, relative bioavailability, and dose p..:
Gregg, R
;
Yun, C
;
Naik, S
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i878-i879 , 2023
Link:
https://doi.org/10.1093/..
?
9
P696 Design and rationale for the multicentre, randomised, ..:
Jairath, V
;
Zou, G
;
Radulescu, G
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i826-i829 , 2023
Link:
https://doi.org/10.1093/..
?
10
P270 A global consensus on the definitions, diagnosis and m..:
Bettenworth, D
;
Baker, M E
;
Bemelmann, W
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i418-i420 , 2023
Link:
https://doi.org/10.1093/..
?
11
OP39 Safety of ustekinumab in IBD: Final pooled long-term s..:
Ghosh, S
;
Feagan, B
;
Ott, E
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i55-i56 , 2023
Link:
https://doi.org/10.1093/..
?
12
P492 Subcutaneous infliximab (CT-P13 SC) as maintenance the..:
Sands, B E
;
Hanauer, S B
;
Colombel, J F
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i623-i624 , 2023
Link:
https://doi.org/10.1093/..
?
13
DOP80 Integrated tissue transcriptomic and serum proteomic ..:
Hassan-Zahraee PhD, M
;
Ye, Z
;
Xi, L
...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i124-i124 , 2022
Link:
https://doi.org/10.1093/..
?
14
A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THER..:
Panaccione, R
;
Ferrante, M
;
Feagan, B G
...
Journal of the Canadian Association of Gastroenterology. 5 (2022) Supplement_1 - p. 43-45 , 2022
Link:
https://doi.org/10.1093/..
?
15
OP23 The efficacy and safety of guselkumab induction therap..:
Dignass, A
;
Rubin, D
;
Bressler, B
...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i025-i026 , 2022
Link:
https://doi.org/10.1093/..
1-15
